Usha
Usha Hanumolu, Cupertino, CA US
Patent application number | Description | Published |
---|---|---|
20130218944 | Consistent Interface for Sales Territory Message Type Set 1 - A business object model, which reflects data that is used during a given business transaction, is utilized to generate interfaces. This business object model facilitates commercial transactions by providing consistent interfaces that are suitable for use across industries, across businesses, and across different departments within a business during a business transaction. In some operations, software creates, updates, or otherwise processes information related to a sales territory business object. | 08-22-2013 |
20130218945 | Consistent Interface for Sales Territory Message Type Set 2 - A business object model, which reflects data that is used during a given business transaction, is utilized to generate interfaces. This business object model facilitates commercial transactions by providing consistent interfaces that are suitable for use across industries, across businesses, and across different departments within a business during a business transaction. In some operations, software creates, updates, or otherwise processes information related to a sales territory business object. | 08-22-2013 |
Usha Karunakaran, Navi Mumbai IN
Patent application number | Description | Published |
---|---|---|
20090182143 | NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - The present invention relates to novel heterocyclic compounds, their analogs, their tautomers, their regioisomers, their stereoisomers, their enantiomers, their diastereomers, their polymorphs, their pharmaceutically acceptable salts, their appropriate N-oxides, their pharmaceutically acceptable solvates and their pharmaceutical compositions containing them. The present invention more particularly relates to novel Phosphodiesterase type 4 (PDE4) inhibitors of the Formula (1), their analogs, tautomers, enantiomers, diasteromers, regioisomers, stereoisomers, polymorphs, pharmaceutically acceptable salts, appropriate N-oxide, pharmaceutically acceptable solvates and the pharmaceutical compositions containing them. | 07-16-2009 |
Usha Kasid, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20100041142 | ANTI-APOPTOTIC GENE SCC-S2 AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF - A gene that is a positive mediator of tumor growth and metastasis in certain cancer types is provided. This gene and corresponding polypeptide have diagnostic and therapeutic application for detecting and treating cancers that involve expression of SCC-S2 such as renal, ovarian, head and neck, breast, prostate, brain, chronic myelogenous leukemia, lung, lymphoblastic leukemia, and colorectal adenocarcinoma cells. | 02-18-2010 |
20110104252 | ANTI-APOPTOTIC GENE SCC-S2 AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF - A gene that is a positive mediator of tumor growth and metastasis in certain cancer types is provided. This gene and corresponding polypeptide have diagnostic and therapeutic application for detecting and treating cancers that involve expression of SCC-S2 such as renal, ovarian, head and neck, breast, prostate, brain, chronic myelogenous leukemia, lung, lymphoblastic leukemia, and colorectal adenocarcinoma cells. | 05-05-2011 |
Usha Kuloor, Fort Washington, PA US
Patent application number | Description | Published |
---|---|---|
20120236769 | INTERFACE FOR LOCAL CONFIGURATION AND MONITORING OF AN INDUSTRIAL FIELD DEVICE WITH SUPPORT FOR PROVISIONING ONTO AN INDUSTRIAL WIRELESS NETWORK AND RELATED SYSTEM AND METHOD - A method includes communicatively coupling a user device to a field device in an industrial control system in order to configure and provision the field device. The method also includes selecting an operating mode of the user device. The method further includes, in response to selecting a first operating mode, providing configuration data from the user device to the field device in order to configure the field device. In addition, the method lo includes, in response to selecting a second operating mode, providing provisioning data from the user device to the field device in order to provision the field device onto a wireless network. Providing the configuration data and the provisioning data could include communicating the provisioning data and the configuration data to the field device through an out-of-band communication interface. The out-of-band communication interface may include a direct wired interface or infrared interface. | 09-20-2012 |
Usha Nagavarapu, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20150284349 | EPIDITHIODIKETOPIPERAZINE COMPOUNDS, COMPOSITIONS, AND METHODS - Epidithiodiketopiperazine compounds, pharmaceutical compositions based thereon and methods of their synthesis, as part of treating, inhibiting and reducing transcription and translation of hypoxia inducible genes are described. | 10-08-2015 |
Usha Nair, Nashville, TN US
Patent application number | Description | Published |
---|---|---|
20110065938 | METHOD FOR THE PREPARATION OF ESCITALOPRAM - A novel method is provided for the manufacture of escitalopram. The method comprises chromatographic separation of the enantiomers of citalopram or an intermediate in the production of citalopram using a chiral stationary phase such as Chiralpakā¢ AD or Chiralcelā¢ OD. Novel chiral intermediates for the synthesis of Escitalopram made by said method are also provided. | 03-17-2011 |
Usha Periyanayagam, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20110040324 | DEVICES AND METHODS FOR PERCUTANEOUS ACCESS, HEMOSTASIS, AND CLOSURE - The present invention provides methods and devices for obtaining percutaneous access, maintaining hemostasis, and providing closure of openings in tissues of the body. In particular, the present invention provides methods and devices for maintaining hemostasis and providing closure surgical incisions of the left ventricular apex of the heart. | 02-17-2011 |
20150087916 | DEVICES AND METHODS FOR PERCUTANEOUS ACCESS, HEMOSTASIS, AND CLOSURE - The present invention provides methods and devices for obtaining percutaneous access, maintaining hemostasis, and providing closure of openings in tissues of the body. In particular, the present invention provides methods and devices for maintaining hemostasis and providing closure surgical incisions of the left ventricular apex of the heart. | 03-26-2015 |
Usha Thulasiram, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20100064275 | EXTRACTING PLATFORM INDEPENDENT MODELS FROM COMPOSITE APPLICATIONS - A system and method for extracting a platform independent model (PIM) from the existing implementation artifacts of a composite application via an intermediary platform specific model (PSM) using model-driven transformations. Meta-models for the PSM and PIM are prepared and mapping rules are specified therebetween. The mapping rules can be created manually or derived automatically via ontology mapping techniques. Once specified, model driven transformations that codify the mapping rules generate the PIM which may include the structural, behavioral and user experience models of the composite application. To enhance the reusability of the extracted PIM, a business level service model along with a service dependency model is generated rather than IT level classes. These higher levels of abstraction enable the models to be linked with business objectives, which is important for companies to understand and maintain their service portfolios. | 03-11-2010 |